EYPT Q1 2017 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

EYPTEyePoint Pharmaceuticals, Inc.

$1B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$590,000+82.1% YoY

Gross Profit

-$3M-463.4% margin

Operating Income

-$5M-874.6% margin

Net Income

-$5M-871.2% margin

EPS (Diluted)

$-1.50

QoQ Revenue Growth

-90.1%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$644,000

Balance Sheet

Total Assets

$18M

Total Liabilities

$5M

Stockholders' Equity

$13M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$590,000	$324,000	+82.1%
Gross Profit	-$3M	-$3M	+0.6%
Operating Income	-$5M	-$5M	-1.3%
Net Income	-$5M	-$5M	-2.0%